Engineered nanoparticles could deliver better targeted cancer treatment
Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard treatment in a preclinical study.
Which childhood abuse survivors are at elevated risk of depression? New study provides important clues
Scientists have identified a pattern of gene activity present in some female survivors of childhood abuse that is associated with an elevated risk of depression.
Which childhood abuse survivors are at elevated risk of depression? New study provides important clues
Scientists have identified a pattern of gene activity present in some female survivors of childhood abuse that is associated with an elevated risk of depression.
2026 SCSD Research Day
Friday February 13 2026 • 3pm to 5pm
McIntyre Building, room 330, 3655 Promenade Sir-William-Osler, Montreal QC, H3A 1A3
2026 SCSD Research Day
Friday February 13 2026 • 3pm to 5pm
McIntyre Building, room 330, 3655 Promenade Sir-William-Osler, Montreal QC, H3A 1A3
CIHR grants $55.9M to McGill health research
56 McGill research projects were awarded funding through CIHR’s Fall 2025 Project Grant competition, to support high-potential health research across all areas and career stages.
CIHR grants $50.4M to McGill health research
51 McGill research projects were awarded funding through CIHR’s Fall 2025 Project Grant competition, to support high-potential health research across all areas and career stages.
Night owl or early bird? Study finds sleep categories aren’t that simple
The familiar labels “night owl” and “early bird,” long used in sleep research, don’t fully capture the diversity of human internal clocks, a new study has found.
The McGill University-led study published in Nature Communications found the two sleep-wake patterns, called chronotypes, contain a total of five distinct biological subtypes, each associated with different patterns of behaviour and health.
Night owl or early bird? Study finds sleep categories aren’t that simple
The familiar labels “night owl” and “early bird,” long used in sleep research, don’t fully capture the diversity of human internal clocks, a new study has found.
The McGill University-led study published in Nature Communications found the two sleep-wake patterns, called chronotypes, contain a total of five distinct biological subtypes, each associated with different patterns of behaviour and health.
RNA therapy may be a solution for infant hydrocephalus
Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs.
Hippocampus does more than store memories: it predicts rewards, study finds
A preclinical study published in Nature has found evidence that the hippocampus, the brain region that stores memory, also reorganizes memories to anticipate future outcomes.
Hippocampus does more than store memories: it predicts rewards, study finds
A preclinical study published in Nature has found evidence that the hippocampus, the brain region that stores memory, also reorganizes memories to anticipate future outcomes.
Weston Family Foundation awards two McGill researchers combatting neurodegenerative diseases of aging
Weston Family Foundation awards two McGill researchers combatting neurodegenerative diseases of aging
Findings suggest that certain medications for Type 2 diabetes reduce risk of dementia
A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.
Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.
The study examined GLP-1 receptor agonists, which include such medications as Ozempic, as well as DPP-4 inhibitors.
Findings suggest that certain medications for Type 2 diabetes reduce risk of dementia
A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.
Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.
The study examined GLP-1 receptor agonists, which include such medications as Ozempic, as well as DPP-4 inhibitors.
Three McGill researchers receive SSHRC Partnership Engage Grants
The Social Science and Humanities Research Council of Canada (SSHRC) announced recipients of the latest Partnership Engage Grants competition, including a total of $73,782 awarded to three McGill researchers.
The 2026 Dr. Donald G. Doehring Memorial Lecture
Thursday March 12 2026 • 4:30pm to 6pm
Dentistry Suite #102, 2001 Avenue McGill College
Anna Papafragou, PhD
Professor • Department of Linguistics, University of Pennsylvania
The 2026 Dr. Donald G. Doehring Memorial Lecture
Thursday March 12 2026 • 4:30pm to 6pm
Dentistry Suite #102, 2001 Avenue McGill College
Anna Papafragou, PhD
Professor • Department of Linguistics, University of Pennsylvania
